DongKoo Bio & Pharma Completes 3 Billion Won Share Buyback
Bitget2026/10/28 02:34- DongKoo Bio & Pharma completed repurchases of 822,134 shares, representing 2.89% of outstanding stock, under a KRW 3 billion trust contract.
- The trust contract will terminate early on Oct. 28, 2026, following completion of the buyback.
- The repurchased shares are slated for cancellation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
